FDA Investigator Paula M Laplant
Paula M Laplant has inspections in 3 countries as of 02 Nov 2023. Paula M Laplant has collaborated with a combined 2600 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
68
Last Inspection Date:
02 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Canada,
India
Co-Investigator(s):
Abby E Pelletier,
Alice S Tsao,
Alois P Provost,
Alysia M Salonia,
Alyssa R Favro,
Amber G Wardwell,
Amy C Jordan,
Andrew J Seaborn,
Andrew M Barlow,
Angela J Davis,
Barbara A Rusin,
Barbara M Frazier,
Bradford L Swanson,
Brandy L Couillard,
Brandy L Gillilan,
Carl A Huffman, III,
Carrie A Hughes,
Christopher T Peters,
Clinton V Giustra,
Concepcion Cruz, Jr,
Courtney N Long,
Craig A Garmendia,
Daniel E Needham,
Daniel L Zheng,
Darin S Wiegers,
Daryl A Dewoskin,
David P Vanhouten,
David S Firley,
Dawn M Braswell,
Dean R Rugnetta,
Devaughn Edwards,
Diane M Prince,
Diantha M Bleau,
Douglas S Joslin,
Dr. Gopa Biswas, PhD,
Edmund F Mrak, Jr,
Edmund Mrak,
Emily J Schramm,
Erica B Raphael,
Erik W Koester,
Garry H Stewart,
George C Amedro,
Gerard D Difiore,
Gordon,
Greg W Hites,
Isaac K Carney,
Ivan E Reyes,
James C Maclaughlin,
James Norman,
James W Whitney,
Jamie S Mathews,
Jason B Prosser,
Jeffery A Hangartner,
Jennifer L Sheehan,
John A Kadavil, PhD,
John P Mistler,
John P Shelton,
John R Carlson,
John S Hartford,
Jonathan G Matrisciano,
Jonathan G Matrsciano,
Jose Velez,
Joseph T Frost,
Joyce A Kellett,
Julianne C Mccullough,
Justin A Boyd,
Justine M Corson,
Karen M Cooper,
Karen M Cruz Arenas,
Karen M Kondas,
Karen M Rodriguez,
Karen Mcnabb Noon,
Kathleen E Mcafoose,
Kenneth H Williams,
Kent A Conforti,
Lakshmi Narasimhan, PhD,
Larry K Austin,
Laura E Garcia,
Laurie A Haxel,
Laurie B Frazier,
Lawrence Y Lee, PhD,
LCDR Debra Emerson,
Li Hongpaul Yeh, PhD,
Lisa P Oakes,
Liz M Otero,
Lori A Holmquist,
Lori M Newman,
Louis Christy,
M Patriciaurphy Murphy,
Margaret M Sands,
Marie A Fadden,
Marion Michaelia,
Marion Michaelis,
Martin J Guardia,
Martin K Yau, PhD,
Matthew D Silverman,
Maxim,
Maya M Davis,
Megan A Haggerty,
Melkamu Getie Kebtie, PhD,
Michael A Charles,
Michael L Casner,
Michelle M Noe,
Nancy A Bellamy,
Nealie C Newberger,
Nichole B Murphy,
Nicola M Fenty Stewart,
Paraluman S Leonin,
Parul M Patel,
Paul P Geraci,
Paula Laplant,
Perry H Gambrell,
Philip Kreiter,
Regina T Brown,
Richard F Hapke,
Richard H Penta,
Robert J Ham,
Robert J Martin,
Robert Mo Brien,
Rory K Geyer,
Samantha J Pinizzotto, D V M,
Samuel T Walker,
Sandra A Hughes,
Sean M Tessicini,
Sean R Marcsisin,
Seongeun Cho (Julia), PhD,
Sharon K Thoma, PharmD,
Slater K Bartlett,
Sripal R Mada, PhD,
Stacey S Degarmo,
State Agency,
Stephen C Smith,
Steven P Donald,
Susan D Yuscius,
Suzanne M Healy,
Tania K Mercado,
Thomas H Jenkins,
Thomas O Morgan,
Troy R Petrillo,
Tyler M Scandalios,
Tyler Scandalios, JD,
Wendy A Johnecheck,
William K Dagley,
Willis I Cobb Jr,
Youmin Wang,
Zachary A Bogorad
Paula M Laplant's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2008 | EIR | Mylan Technologies Inc. - EIR, 2008-06-05 |
January, 2005 | EIR | Mylan Technologies Inc. - EIR, 2005-01-07 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more